miRNAs and ovarian cancer: An overview
- PMID: 28703277
- DOI: 10.1002/jcp.26095
miRNAs and ovarian cancer: An overview
Abstract
Ovarian cancer (OC) is the sixth most common cancer in women globally. However, even with the advances in detection and therapeutics it still represents the most dangerous gynecologic malignancy in women of the industrialized countries. The discovery of micro-RNAs (miRNA), a small noncoding RNA molecule targeting multiple mRNAs and regulation of gene expression by triggering translation repression and/or RNA degradation, has revealed the existence of a new array for regulation of genes involved in cancer. This review summarizes the current knowledge regarding the role of miRNAs expression in OC. It also provides information about potential clinical relevance of circulating miRNAs for OC diagnosis, prognosis, and therapeutics. The identification of functional targets for miRNAs represents a major obstacle in our understanding of microRNA function in OC, but significant progress is being made. The better understanding of the role of microRNA expression in ovarian cancer may provide new array for the detection, diagnosis, and therapy of the OC.
Keywords: gynecologic malignancy; miRNA; ovarian cancer.
© 2017 Wiley Periodicals, Inc.
Similar articles
-
The Role of miRNA in Ovarian Cancer: an Overview.Reprod Sci. 2022 Oct;29(10):2760-2767. doi: 10.1007/s43032-021-00717-w. Epub 2022 Jan 1. Reprod Sci. 2022. PMID: 34973152 Free PMC article. Review.
-
MicroRNA signatures in human ovarian cancer.Cancer Res. 2007 Sep 15;67(18):8699-707. doi: 10.1158/0008-5472.CAN-07-1936. Cancer Res. 2007. PMID: 17875710
-
Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.Biomed Pharmacother. 2016 Dec;84:592-600. doi: 10.1016/j.biopha.2016.09.087. Epub 2016 Sep 30. Biomed Pharmacother. 2016. PMID: 27694003 Review.
-
Clinical relevance of circulating cell-free microRNAs in ovarian cancer.Mol Cancer. 2016 Jun 24;15(1):48. doi: 10.1186/s12943-016-0536-0. Mol Cancer. 2016. PMID: 27343009 Free PMC article. Review.
-
MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.Int J Environ Res Public Health. 2019 Apr 29;16(9):1510. doi: 10.3390/ijerph16091510. Int J Environ Res Public Health. 2019. PMID: 31035447 Free PMC article. Review.
Cited by
-
Circular RNA PCDH10 regulates the tumorigenesis of pancreatic cancer through the miR-338-3p/hTERT axis.Am J Transl Res. 2021 Apr 15;13(4):2181-2197. eCollection 2021. Am J Transl Res. 2021. PMID: 34017382 Free PMC article.
-
Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer.Aging (Albany NY). 2019 Dec 3;11(23):11416-11439. doi: 10.18632/aging.102538. Epub 2019 Dec 3. Aging (Albany NY). 2019. PMID: 31794425 Free PMC article.
-
Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response.Front Pharmacol. 2023 Mar 31;14:1162045. doi: 10.3389/fphar.2023.1162045. eCollection 2023. Front Pharmacol. 2023. PMID: 37063265 Free PMC article. Review.
-
Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer.Cancers (Basel). 2021 Apr 12;13(8):1839. doi: 10.3390/cancers13081839. Cancers (Basel). 2021. PMID: 33921525 Free PMC article. Review.
-
microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance.Genes Cancer. 2020;11(1-2):20-42. doi: 10.18632/genesandcancer.202. Genes Cancer. 2020. PMID: 32577155 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical